Nicolotti R A, Kochibe N, Kinsky S C
J Immunol. 1976 Nov;117(5 Pt.2):1898-902.
This study describes some of the parameters that quantitatively or qualitatively influence the immunogenicity in guinea pigs of synthetic lipid antigens: phosphatidylethanolamine (PE) derivatives in which the amino (N) group has been substituted with either dinitrophenyl (DNP), dinitrophenylaminocaproyl (DNP-Cap), fluoresceinthiocarbamyl (Fl), or mono (p-azobenzenearsonic acid) throsyl (ABA-Tyr) residues. Previous experiments have shown that the non-covalent insertion of DNP-Cap-PE and ABA-Tyr-PE into the same lipid bilayers of sphingomyelincholesterol-dicetylphosphate liposomes markedly enhanced anti-DNP-Cap antibody formation over that produced by liposomes sensitized with only DNP-Cap-PE. The humoral response to Fl-PE and CNP-PE-sensitized liposomes is also augmented by the simultaneous incorporation of ABA-Tyr-PE. Moreover, micelles containing both DNP-Cap-PE and ABA-Tyr-PE induce more antibodies to the DNP-Cap deteminant than do micelles of DNP-Cap-PE alone, or a mixture of DNP-Cap-PE and ABA-Tyr-PE micelles. Nevertheless, in regard to a humoral response, liposomes were more potent immunogens than were their micellar counterparts. Of all the N-substituted derivatives examined so far, ABA-Tyr-PE is unique in that it can elicit cell-mediated immunity in addition to antibodies. The cellular response to ABA-Tyr-PE is not, however, stimulated by incorporation into liposomal bilayers and requires administration of either micelles or liposomes in complete Freund's adjuvant. In contrast, the ability of ABA-Tyr-PE to enhance a humoral response to another N-substituted PE derivative present in the same immunogen is also observed when the latter are given with incomplete Freund's adjuvant. The relationship of these findings to the immunogenicity of naturally occurring lipid antigens, as well as conventional immunogens having at least one determinant covalently attached to a protein carrier is discussed.
二硝基苯基(DNP)、二硝基苯基氨基己酰基(DNP-Cap)、异硫氰酸荧光素(Fl)或单(对-偶氮苯胂酸)苏糖基(ABA-Tyr)残基取代了氨基(N)基团的磷脂酰乙醇胺(PE)衍生物。先前的实验表明,将DNP-Cap-PE和ABA-Tyr-PE非共价插入鞘磷脂-胆固醇-二鲸蜡基磷酸酯脂质体的同一脂质双层中,与仅用DNP-Cap-PE致敏的脂质体相比,能显著增强抗DNP-Cap抗体的形成。同时加入ABA-Tyr-PE也能增强对Fl-PE和CNP-PE致敏脂质体的体液反应。此外,含有DNP-Cap-PE和ABA-Tyr-PE的胶束比单独的DNP-Cap-PE胶束或DNP-Cap-PE与ABA-Tyr-PE胶束的混合物诱导出更多针对DNP-Cap决定簇的抗体。然而,就体液反应而言,脂质体比其胶束对应物更具免疫原性。在迄今为止检测的所有N-取代衍生物中,ABA-Tyr-PE的独特之处在于,除了抗体外,它还能引发细胞介导的免疫。然而,将ABA-Tyr-PE掺入脂质体双层并不能刺激细胞反应,且需要在完全弗氏佐剂中给予胶束或脂质体。相反,当后者与不完全弗氏佐剂一起给予时,也观察到ABA-Tyr-PE增强对同一免疫原中另一种N-取代PE衍生物的体液反应的能力。讨论了这些发现与天然存在的脂质抗原以及至少有一个决定簇共价连接到蛋白质载体上的传统免疫原的免疫原性之间的关系。